Intermittent dosing on HIV dual therapy leads to higher rate of treatment failure
Dolutegravir may increase blood clotting affecting stroke and heart attack risk, early findings warn
Reduced-drug treatment becoming common in Paris
Reduced-drug or intermittent treatment reduced HIV drug costs by 29% between 2015 and 2022
Increasing and changing pattern of treatment switches among people with HIV
Body mass index is sufficient to predict diabetes or metabolic syndrome, Italian study finds
More information needed on ethnic differences
Some women in France are using PrEP, but only transgender women tend to stay on it
HIV services in Ukraine resilient but starting to feel the strain
PD-1 inhibitor budigalimab may delay viral rebound
Long-acting injectable treatment highly effective in European cohort studies
Five cases of viral rebound on injectable treatment puzzle researchers